VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults
Trial Status: administratively complete
The purpose of the trial is to evaluate the safety and efficacy of a new antifungal with a novel mechanism of action in immunocompromised adults with invasive aspergillosis.